Global Human Microbiome Market

Around Trillions of microorganisms that survive in and on the human body are referred to as human microbiome. Human microbiome comprises of the collective population of microbes such as fungi, bacteria, and archaea which have evolved with their human species, owing to their mutualistic relationship with their hosts. According to recent groundbreaking research, scientists have shown that these microbes play a crucial role in maintaining the immune system and contributing to the digestion of food, vitamin synthesis, and brain function. Hence Human microbiome as a market is an upcoming trend to look out for. The enormous benefits of human microbiome which is slowly being revealed in the form of therapies like prebiotics, probiotics etc.

End-user/Technology

The end users are hospitals, specialized clinicsand ambulatory surgery centers

Market Dynamics

With ever increasing incidence of several types of lifestyle diseases, growing geriatric population, diarrheal infections, autoimmune disorders, the demand for a more revolutionary and life changing drug is needed. And with advancement in biomedical science, more research is being put forth, for developing product as well as technology.

Though this whole new field in biomedical science is new and is still at infancy, it is emerging as a market full of growth promises. Just that there exists less awareness about this area along with lack of comprehensive research. Also stringent government regulations may turn out as a restraint.

Market Segmentation

The human microbiome market can be broadly categorized based on:

--> Applications basically into therapeutics and diagnostics

--> Disease like obesity, diabetes, autoimmune disorders, cancer, acute diarrhea, central nervous system disorders and others

--> Products like probiotics, prebiotics, synbiotics, medical foods and other supplements

--> Geography

Regional/Geographic Analysis

On the basis of Geography, the market can be segmented into North America, Europe, Asia-Pacific, Middle East and Africa and Latin America. While the North America and Europe human microbiome markets account for the largest chunk of share, The U.S. represents the largest market for human microbiome. Following U.S, Canada in North America. France, Germany, Spain and the U.K. also hold a major share of human microbiome market in Europe. Though, it is estimated that Asia-Pacific glucose monitoring market as emerging market would grow at the highest CAGR in the forecast period. Due to improvement in research infrastructure in the region along with improved purchasing power of patients. China and India are expected to be the fastest growing human microbiome markets in Asia.

Opportunities

Global human microbiome market is expected to grow at a CAGR of XX % during 2018-2023.Growing R&D Investment along with investment in new drugs provides global opportunities especially in emrging market

Key Players

--> Metabiomics Corporation (U.S.)

--> Yakult (Japan), DuPont (U.S.)

--> Enterome Bioscience (France)

--> ViThera Pharmaceuticals (U.S.)

--> Second Genome Inc. (U.S.)

--> MicroBiome Therapeutics LLC (U.S.)

--> Vedanta BioSciences (U.S.)

--> Osel (U.S.), and Merck (U.S.)

--> Others.

Report Contents:

> Market segments

> Market Drivers, Restraints and Opportunities

> Market Size & Forecast 2016 to 2022

> Supply & Demand Value Chain

> Market - Current Trends

> Competition & Major Companies

> Technology and R&D Status

> Porters Five Force Analysis

> Strategic and Critical Success Factor Analysis of Key Players

Regional Analysis:

> North America

>> US and Canada

> Latin America

>> Mexico, Brazil, Argentina and Rest of Latin America

> Western Europe

>> EU5 (Germany, France, Italy, Spain, U.K.)

>> Nordic Countries (Denmark, Finland, Norway, and Sweden)

>> Benelux (Belgium, The Netherlands, and Luxembourg)

>> Rest of Western Europe

> Eastern Europe

>> Russia

>> Poland

>> Rest of Eastern Europe

> Asia Pacific

>> China

>> India

>> Japan

>> Australia and New Zealand

>> Rest of Asia Pacific

> Middle East and Africa

>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)

>> South Africa

>> North Africa

>> Rest of Middle East and Africa

This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.

Report Highlights:

> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)

> Consumer and Pricing Analysis

> Market dynamics of the industry

> Market Segmentation

> Estimated Market Sizing in terms of volume and value

> Recent trends in Market and impact

> Research Status and Technology Overview

> Extensive Industry Structure Coverage